Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 76–100 of 566 matching trials (filtered from 7,816) · page 4 of 23, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
NCT07512193
Active tES; Cognitive Interventions
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 10 Johns Hopkins University
OTHER
2026-09-02
Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation
NCT07607730
Regulating Together group therapy
Runs in: United States · 1 site
NA
other
RECRUITING 10 Children's Mercy Hospital Kansas City
OTHER
2026-09-02
Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment
NCT07638748
Virtual Reality (VR) sessions
Runs in: United States · 1 site
NA
other
RECRUITING 10 The University of Texas Health Science Center, Houston
OTHER
2026-09-02
Wearable Sensor for Early Detection and Monitoring of Cognitive Decline
NCT07780162
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 100 BioSensics
INDUSTRY
2026-09-02
Probiotic Milk Drink for Gut and Brain Health in Older Adults and Caregivers
NCT07800195
Probiotic Fermented Milk (PFM) Drink; Placebo
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 40 University of South Florida
OTHER
2026-09-02
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
NCT04124029
No Intervention is used for this study but all subjects will be ask...
Runs in: United States · 1 site
NA
other
RECRUITING 800 VA Office of Research and Development
OTHER_GOV
2026-09-01
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
NCT04262206
Atorvastatin 40 Mg Oral Tablet; Placebo oral tablet
Runs in: Puerto Rico; United States · 106 sites
PHASE4
other
RECRUITING 20,000 Duke University
OTHER
2026-09-01
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
NCT06808984
BMS-986368; Placebo
Runs in: Argentina; Australia; China; United States · 78 sites
PHASE2
other
RECRUITING 120 Celgene
INDUSTRY
2026-09-01
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
NCT07091279
Propranolol; Placebo
Runs in: United States · 2 sites
PHASE2
other
RECRUITING 60 Jeremy Veenstra-vanderweele
OTHER
2026-09-01
Terazosin And Metabolic Engagement in Alzheimer's Disease
NCT07796308
Terazosin (Hytrin); Placebo
Runs in: United States · 1 site
PHASE2
other
NOT_YET_RECRUITING 100 Qiang Zhang
OTHER
2026-09-01
Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers
NCT07796347
Dyadic Life Review
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 120 University of Rochester
OTHER
2026-09-01
Biofluid Research on Age-Related or Inherited Neurodegeneration
NCT07798700
Runs in: United States · 1 site
NA
other
RECRUITING 1,000 University of Pennsylvania
OTHER
2026-09-01
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
NCT05887973
The T.R.I.G.G.E.R Project
Runs in: United States · 1 site
NA
other
RECRUITING 250 University of Michigan
OTHER
2026-08-31
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673
ACP-204; Placebo
Runs in: Brazil; Bulgaria; Chile; Czechia; France; Italy; Mexico; ... · 149 sites
PHASE2|PHASE3
other
RECRUITING 1,074 ACADIA Pharmaceuticals Inc.
INDUSTRY
2026-08-31
A Study of AMDX-2011P in Participants With Alzheimer's Disease
NCT06514001
AMDX-2011P
Runs in: United States · 1 site
PHASE2
other
RECRUITING 25 Amydis Inc.
INDUSTRY
2026-08-31
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
NCT06540833
ITI-1284; Placebo
Runs in: Bulgaria; Croatia; Czechia; Italy; Poland; Romania; Serbi... · 67 sites
PHASE2
other
RECRUITING 370 Intra-Cellular Therapies, Inc.
INDUSTRY
2026-08-31
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
NCT07326709
Votoplam (blinded); Placebo
Runs in: Argentina; Australia; Belgium; Bulgaria; Canada; China; C... · 82 sites
PHASE3
other
RECRUITING 770 Novartis Pharmaceuticals
INDUSTRY
2026-08-31
Transforming Maternal Mental Health Care
NCT07766174
Lōvu platform; Standard Care Arm
Runs in: United States · 1 site
NA
other
RECRUITING 50 University of Utah
OTHER
2026-08-31
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
NCT07794956
LpD3.5; Placebo
Runs in: United States · 1 site
EARLY_PHASE1
other
RECRUITING 15 University of South Florida
OTHER
2026-08-31
Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease
NCT07795307
Emtricitabine and tenofovir disoproxil fumarate combination; Placebo
Runs in: United States · 1 site
PHASE1
other
NOT_YET_RECRUITING 20 Brigham and Women's Hospital
OTHER
2026-08-31
PrP-targeting siRNA Safety & Mechanism Study
NCT07444580
PrP-siRNA
Runs in: United States · 5 sites
PHASE1
other
RECRUITING 30 Broad Institute of MIT and Harvard
OTHER
2026-08-28
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
NCT07633470
Zunveyl®
Runs in: United States · 14 sites
PHASE4
other
RECRUITING 150 Alpha Cognition, Inc
INDUSTRY
2026-08-28
Momentary Coping Prompts and Hair Steroids in College Students
NCT07782398
Momentary coping prompt; Active control message
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 80 University of Florida
OTHER
2026-08-28
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192
ML-007C-MA; Placebo
Runs in: Argentina; Bulgaria; Canada; Czechia; France; Hungary; It... · 55 sites
PHASE2
other
RECRUITING 300 MapLight Therapeutics
INDUSTRY
2026-08-27
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
NCT07787169
LY4405094; LY4405094; Placebo; Placebo; Florbetapir F18; Florbetaben F 18
Runs in: United States · 10 sites
PHASE1
other
NOT_YET_RECRUITING 179 Eli Lilly and Company
INDUSTRY
2026-08-27

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

Last updated

From the research library

The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 289 studies on Clinical trials →